Press release
Kidney Cancer Drugs Market 2018-2023 Size, Share, Trends & Top Key Players: Baxter, Roche, GlaxoSmithKline, Novartis, Pfizer, Abbott Laboratories, Active Biotech, Amgen, Argos Therapeutics, ArQule, AVEO Pharmaceuticals, Bionomics, Bristol-Myers Squibb
Kidney Cancer Drugs Market
In this report, covers the present scenario (with the base year being 2017) and the growth prospects of global Kidney Cancer Drugs market for 2018-2023. Over the next five years, projects that Kidney Cancer Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/1257406
The key manufacturers covered in this report:
Baxter, Roche, GlaxoSmithKline, Novartis, Pfizer, Abbott Laboratories, Active Biotech, Amgen, Argos Therapeutics, ArQule, AVEO Pharmaceuticals, Bionomics, Bristol-Myers Squibb, Cerulean Pharma, Exelixis, Genentech, Immatics biotechnologies, Immunicum, Ono Pharmaceutical, Onyx Therapeutics, Oxford BioMedica, Prometheus Laboratories,Seattle Genetics, Taiwan Liposome, Tracon Pharmaceuticals, Wilex
Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed.
The different types of kidney cancer (such as RCC and TCC) develop in different ways, meaning that the diseases have different long term outcomes, and need to be staged and treated in different ways. RCC is responsible for approximately 80% of primary renal cancers, and TCC accounts the majority of the remainder.
Biological therapies are drugs which are used to kill cancer cells or stop them from growing. Biological therapies are used to try to shrink or control advanced kidney cancer and help people to live longer. You may be given biological therapies for kidney cancer that has already spread, or is at high-risk of coming back after surgery.
This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Cancer Drugs market by product type, application, key manufacturers and key regions.
To calculate the market size, considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Segmentation by application:
Renal cell carcinoma (RCC)
Transitional cell carcinoma (TCC)
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.
Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/1257406
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Kidney Cancer Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Kidney Cancer Drugs market by identifying its various subsegments.
Focuses on the key global Kidney Cancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Kidney Cancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Kidney Cancer Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Kidney Cancer Drugs Consumption Market Report
1 Scope of the Report
2 Executive Summary
3 Global Kidney Cancer Drugs by Players
4 Kidney Cancer Drugs by Regions
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Marketing, Distributors and Customer
11 Global Kidney Cancer Drugs Market Forecast
12 Key Players Analysis
12.1 Baxter
12.1.1 Company Details
12.1.2 Kidney Cancer Drugs Product Offered
12.1.3 Bayer Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Roche
12.2.1 Company Details
12.2.2 Kidney Cancer Drugs Product Offered
12.2.3 Roche Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Roche News
12.3 GlaxoSmithKline
12.3.1 Company Details
12.3.2 Kidney Cancer Drugs Product Offered
12.3.3 GlaxoSmithKline Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 GlaxoSmithKline News
12.4 Novartis
12.4.1 Company Details
12.4.2 Kidney Cancer Drugs Product Offered
12.4.3 Novartis Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Novartis News
12.5 Pfizer
12.5.1 Company Details
12.5.2 Kidney Cancer Drugs Product Offered
12.5.3 Pfizer Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Pfizer News
12.6 Abbott Laboratories
12.6.1 Company Details
12.6.2 Kidney Cancer Drugs Product Offered
12.6.3 Abbott Laboratories Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Abbott Laboratories News
12.7 Active Biotech
12.7.1 Company Details
12.7.2 Kidney Cancer Drugs Product Offered
12.7.3 Active Biotech Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Active Biotech News
12.8 Amgen
12.8.1 Company Details
12.8.2 Kidney Cancer Drugs Product Offered
12.8.3 Amgen Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Amgen News
12.9 Argos Therapeutics
12.9.1 Company Details
12.9.2 Kidney Cancer Drugs Product Offered
12.9.3 Argos Therapeutics Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Argos Therapeutics News
12.10 ArQule
12.10.1 Company Details
12.10.2 Kidney Cancer Drugs Product Offered
12.10.3 ArQule Kidney Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 ArQule News
12.11 AVEO Pharmaceuticals
12.12 Bionomics
12.13 Bristol-Myers Squibb
12.14 Cerulean Pharma
12.15 Exelixis
12.16 Genentech
12.17 immatics biotechnologies
12.18 Immunicum
12.19 Ono Pharmaceutical
12.20 Onyx Therapeutics
12.21 Oxford BioMedica
12.22 Prometheus Laboratories
12.23 Seattle Genetics
12.24 Taiwan Liposome
12.25 Tracon Pharmaceuticals
12.26 Wilex
13 Research Findings and Conclusion
Complete report at https://www.marketstudyreport.com/reports/2018-2023-global-kidney-cancer-drugs-consumption-market-report
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Drugs Market 2018-2023 Size, Share, Trends & Top Key Players: Baxter, Roche, GlaxoSmithKline, Novartis, Pfizer, Abbott Laboratories, Active Biotech, Amgen, Argos Therapeutics, ArQule, AVEO Pharmaceuticals, Bionomics, Bristol-Myers Squibb here
News-ID: 1370591 • Views: …
More Releases from marketstudyreport.com
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders.
Load Bank Market Size was estimated…
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of…
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028.
The operation is done to stop ligament tears and…
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting…
More Releases for Kidney
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Kidney Cancer Association Partners with Conquer Cancer Foundation to Fund Kidney …
For over a decade, the Kidney Cancer Association has assisted with funding the Conquer Cancer Foundation of ASCO's Young Investigator Award. The award provides funding to promising doctors to pursue careers in kidney cancer research.
“Conquer Cancer truly appreciates the generous and ongoing support of the Kidney Cancer Association as we work together to advance cutting-edge research and treatments for kidney cancer. We value this partnership which supports kidney cancer research…
Kidney Cancer Drugs Market: Rising Incidence of Kidney Cancer Expected to Boost …
With only a handful of large vendors accounting collectively for a large share, the vendor landscape of the global market for kidney cancer drugs can be viewed as largely consolidated and tough to crack for new vendors, observes Transparency Market Research in a recent report. The level of competition among leading players is also quite stiff.
Among the leading players, Pfizer, Inc. accounted for the maximum share in the overall market…
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA
Major scientific sessions:
Kidney Fluid, Electrolytes, Acid-Base Disorders
Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders
Chronic Kidney Disease (CKD) Kidney and Bladder stones
Dialysis and Renal Care Urology/Urinary Tract Infections
Kidney Transplantation Geriatric-Genetic Kidney…
